Guerin C, Laterra J, Hruban R H, Brem H, Drewes L R, Goldstein G W
Department of Neurosurgery, Johns Hopkins Hospital, Baltimore, MD 21205.
Ann Neurol. 1990 Dec;28(6):758-65. doi: 10.1002/ana.410280606.
The glucose transporter of the human brain has been localized to endothelial cells expressing the blood-brain barrier, but little is known regarding its mechanism of induction or whether its expression is exclusively linked with restricted vascular permeability. We investigated glucose transporter expression by vessels in human astrocytic tumors and pulmonary metastases to the brain using immunohistochemical techniques. Vessels in 9 of 10 low-grade astrocytomas and 8 of 10 anaplastic astrocytomas were positive for glucose transporter. Glioblastoma vessels were transporter-positive in only 2 of 10 specimens. Vessels in all three metastatic tumors were negative for the glucose transporter. The decrease in transporter expression observed in higher-grade tumors occurred independently of increases in vascular permeability. In low-grade astrocytomas and glioblastomas transporter expression and contrast enhancement were inversely related, but vessels in 6 of 9 anaplastic astrocytomas were transporter-positive despite contrast enhancement. These findings suggest that separate mechanisms induce the glucose transporter and the permeability restrictions of the human blood-brain barrier. They also have potential implications for the therapy and prognosis of astroglial neoplasms.
人类大脑的葡萄糖转运蛋白已定位到表达血脑屏障的内皮细胞,但对其诱导机制或其表达是否仅与血管通透性受限相关了解甚少。我们使用免疫组织化学技术研究了人类星形细胞瘤和脑肺转移瘤中血管的葡萄糖转运蛋白表达情况。10例低级别星形细胞瘤中的9例以及10例间变性星形细胞瘤中的8例血管葡萄糖转运蛋白呈阳性。胶质母细胞瘤血管在10个标本中仅有2例呈转运蛋白阳性。所有3例转移瘤的血管葡萄糖转运蛋白均为阴性。在高级别肿瘤中观察到的转运蛋白表达降低与血管通透性增加无关。在低级别星形细胞瘤和胶质母细胞瘤中,转运蛋白表达与对比增强呈负相关,但9例间变性星形细胞瘤中有6例的血管尽管有对比增强但仍呈转运蛋白阳性。这些发现表明,诱导葡萄糖转运蛋白和人类血脑屏障通透性限制的机制是不同的。它们对星形胶质细胞瘤的治疗和预后也具有潜在意义。